Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Thymidylate synthase inhibitors.
Touroutoglou N, Pazdur R. Touroutoglou N, et al. Clin Cancer Res. 1996 Feb;2(2):227-43. Clin Cancer Res. 1996. PMID: 9816165 Review.
Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia.
Treon SP, Hansen M, Branagan AR, Verselis S, Emmanouilides C, Kimby E, Frankel SR, Touroutoglou N, Turnbull B, Anderson KC, Maloney DG, Fox EA. Treon SP, et al. Among authors: touroutoglou n. J Clin Oncol. 2005 Jan 20;23(3):474-81. doi: 10.1200/JCO.2005.06.059. J Clin Oncol. 2005. PMID: 15659493 Clinical Trial.
Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study.
Emmanouilides C, Sfakiotaki G, Androulakis N, Kalbakis K, Christophylakis C, Kalykaki A, Vamvakas L, Kotsakis A, Agelaki S, Diamandidou E, Touroutoglou N, Chatzidakis A, Georgoulias V, Mavroudis D, Souglakos J. Emmanouilides C, et al. Among authors: touroutoglou n. BMC Cancer. 2007 May 30;7:91. doi: 10.1186/1471-2407-7-91. BMC Cancer. 2007. PMID: 17537235 Free PMC article. Clinical Trial.
Comprehensive tumor molecular profile analysis in clinical practice.
Özdoğan M, Papadopoulou E, Tsoulos N, Tsantikidi A, Mariatou VM, Tsaousis G, Kapeni E, Bourkoula E, Fotiou D, Kapetsis G, Boukovinas I, Touroutoglou N, Fassas A, Adamidis A, Kosmidis P, Trafalis D, Galani E, Lypas G, Orhan B, Tansan S, Özatlı T, Kırca O, Çakır O, Nasioulas G. Özdoğan M, et al. Among authors: touroutoglou n. BMC Med Genomics. 2021 Apr 14;14(1):105. doi: 10.1186/s12920-021-00952-9. BMC Med Genomics. 2021. PMID: 33853586 Free PMC article.
KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study.
Negru S, Papadopoulou E, Apessos A, Stanculeanu DL, Ciuleanu E, Volovat C, Croitoru A, Kakolyris S, Aravantinos G, Ziras N, Athanasiadis E, Touroutoglou N, Pavlidis N, Kalofonos HP, Nasioulas G. Negru S, et al. Among authors: touroutoglou n. BMJ Open. 2014 May 23;4(5):e004652. doi: 10.1136/bmjopen-2013-004652. BMJ Open. 2014. PMID: 24859998 Free PMC article.
Rectal cancer: multimodal treatment approach.
Pramateftakis MG, Kanellos D, Tekkis PP, Touroutoglou N, Kanellos I. Pramateftakis MG, et al. Among authors: touroutoglou n. Int J Surg Oncol. 2012;2012:279341. doi: 10.1155/2012/279341. Epub 2012 Sep 12. Int J Surg Oncol. 2012. PMID: 23008766 Free PMC article. No abstract available.